Skip to the page

Data / Drug companies / Adenosine

Adenosine: 15 companies and 56 products in the FDA NDC directory

Adenosine is listed in the FDA National Drug Code Directory by 15 companies, with 56 products in commercial distribution. 30 of the products (53.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection; liquid, and the newest product started marketing on April 30, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
15
Products
56
Generic (ANDA) products
30 (53.6%)
Application numbers
10
Routes
Intravenous, Topical, Vaginal
Brand names
Yoma Ampoule Plus Collagen Mask Pack, Reorganic Feminine Wash, Sferangs Collagen Synergy Ampoule, The Skin House Wrinkle Collagen Ampoule, The Skinhouse Black Snail Wrinkle, Sferangs Collagen Recharging Toner, Yoma Ampoule Plus Ginseng Mask Pack, Tenue 24K Gold Ampoule
openFDA record search
api.fda.gov

Companies that list adenosine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Noksibcho Cosmetic Co., Ltd.19cream; liquidOther unapproved drugsJuly 1, 2021
Laon Commerce Co LTD7liquid; gelOther unapproved drugsJuly 1, 2023
HF Acquisition Co LLC, DBA HealthFirst5injection, solution; injectionGeneric drugs (ANDA)June 23, 2023
Mylan Institutional LLC4injection; injection, solutionGeneric drugs (ANDA)May 8, 2018
Fresenius Kabi USA, LLC3injection, solutionGeneric drugs (ANDA)April 16, 2018
Gland Pharma Limited3solution; injectionGeneric drugs (ANDA)January 13, 2017
Eugia US LLC2injection, solutionGeneric drugs (ANDA)November 2, 2017
Medical Purchasing Solutions, LLC2injectionGeneric drugs (ANDA)March 15, 2023
Meitheal Pharmaceuticals Inc.2injection, solutionGeneric drugs (ANDA)April 30, 2025
NorthStar Rx LLC2injection, solutionGeneric drugs (ANDA)August 1, 2022
ProPharma Distribution2injectionGeneric drugs (ANDA)March 15, 2023
Sagent Pharmaceuticals2injectionGeneric drugs (ANDA)March 15, 2023
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.1injection, solutionGeneric drugs (ANDA)March 1, 2021
Mylan Institutional LLC1injectionGeneric drugs (ANDA)April 6, 2022
Remedyrepack Inc.1injectionGeneric drugs (ANDA)October 10, 2024

Dosage forms

Dosage formProductsShare
Injection, solution1526.8%
Injection1323.2%
Liquid1221.4%
Cream1119.6%
Gel23.6%
Solution23.6%
Emulsion11.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3053.6%
Other unapproved drugs2646.4%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.